BOSCH Packaging Technology
INTERPHEX Booth No. 3106
INTERPHEX created a quick questionnaire to learn more
about Robert Bosch Packaging Technology, Inc. and
their technology. In this exhibitor spotlight, Tony Miller,
Marketing and Communications Supervisor, answers our
INTERPHEX: How has the industry changed/evolved?
Tony Miller (Robert Bosch Packaging Technology, Inc.):
Many global drug producers have shifted their focus to the
development of new formulations. Hence, they have out-sourced their filling, closing, and packaging operations to
contract manufacturing organizations (CMOs) whose main
concerns are flexibility and productivity. Packaging equipment must be adaptable to different products, packaging
formats, and speeds at consistently high output rates.
In parallel, biopharmaceutical companies, laboratories,
and research facilities are producing smaller amounts of
targeted drugs. This requires flexible platforms that can
handle small batches while ensuring the highest safety for
both operators and products.
Regulations have increased significantly across the
industry. Serialization is just one example. Not only do
pharmaceutical manufacturers need to equip their packaging with serialization codes, but they must also establish
new procedures for the management and storage of serial
numbers, which in turn requires the adaptation of their
INTERPHEX: Can you describe three aspects that have
allowed your company to succeed?
Miller: The first aspect is quality. In a highly price-sensi-tive market with increasingly strict regulations, pharmaceutical producers need to find machines and lines that
offer cost-effectiveness in the long run, as well as the
highest quality output at all times.
The second aspect that makes Bosch Packaging
Technology so successful is continuous growth—both in
numbers and in technologies. By integrating new technologies into the portfolio, we are able to offer our customers
everything from a single source—from a combination of
standard machine platforms to highly customized solutions.
Last, but not least, our customers receive far more than
just a large equipment portfolio. We offer them support
right from the beginning of their projects. With additional
services and comprehensive consulting before, during,
and after start-up, Bosch ensures that all customer needs
are satisfied. This includes qualification and validation
of the lines, as well as trainings and after-sales services.
Beyond machine technology, Bosch supports customers
with market-specific expertise, as well as detailed project
and integration competence.
INTERPHEX: What distinguishes your company from
others in the industry?
Miller: In a nutshell, it’s all about line competence. This
not only includes a large number of different technologies
to choose from, but it also means having one single point
of contact, as well as receiving optimally compatible machines and software solutions to form a complete line.
For customers, it is most important that we understand
what they are looking for: which technology will best
match their new products or their established processes.
This is why our focus is on understanding the pharmaceutical needs. This way, we base all our new developments
on therapeutic areas and their specific requirements.
INTERPHEX: Where do you see the industry going in the
next 10 years?
Miller: In 10 years, a much larger share of pharmaceuticals
will be produced in smaller batch sizes driven by the requirement for specialty medication. For instance, as far as
parenteral packaging is concerned, the amount of pre-steril-ized vials and cartridges in the market will grow significantly,
offering increased flexibility. We will also see new and
unknown pack styles combined with drug delivery devices
emerge, which will be tailored to various patient groups.
Efficiency in terms of both cost and energy will further
drive innovative solutions. The pharmaceutical industry
will be focusing even more on quality, safety, and new
manufacturing methods. Furthermore, Connected Industry
solutions will provide full transparency of the production
and supply chain, thus providing significantly improved
quality and efficiency.
INTERPHEX: What don't most people realize about you
or your company?
Miller: The entire Bosch group is very active in charitable
initiatives. The Bosch Foundation (Robert Bosch Stiftung) is
one of the major German foundations associated with a private company and has managed the philanthropic bequest
of company founder Robert Bosch for over 50 years. n